Kubica, K. and Mazurek, A. (2016) “VEMURAFENIB AS A SELECTIVE INHIBITOR OF THE SERINE/THREONINE-PROTEIN KINASE B-RAF, USED IN THE TREATMENT OF MELANOMA”, Prospects in Pharmaceutical Sciences, 14(8), pp. 52–56. doi: 10.56782/pps.117.